Browse > Article
http://dx.doi.org/10.5487/TR.2008.24.3.161

Methylated Organic Metabolites of Arsenic and their Cardiovascular Toxicities  

Bae, Ok-Nam (College of Pharmacy, Institute of Pharmaceutical Sciences, Seoul National University)
Lim, Kyung-Min (College of Pharmacy, Institute of Pharmaceutical Sciences, Seoul National University)
Noh, Ji-Yoon (College of Pharmacy, Institute of Pharmaceutical Sciences, Seoul National University)
Kim, Keun-Young (College of Pharmacy, Institute of Pharmaceutical Sciences, Seoul National University)
Lim, Eun-Kyung (College of Pharmacy, Institute of Pharmaceutical Sciences, Seoul National University)
Chung, Jin-Ho (College of Pharmacy, Institute of Pharmaceutical Sciences, Seoul National University)
Publication Information
Toxicological Research / v.24, no.3, 2008 , pp. 161-167 More about this Journal
Abstract
Recently, arsenic-toxicity has become the major focus of strenuous assessment and dynamic research from the academy and regulatory agency. To elucidate the cause and the mechanism underlying the serious adverse health effects from chronic ingestion of arsenic-contaminated drinking water, numerous studies have been directed on the investigation of arsenic-toxicity using various in vitro as well as in vivo systems. Neverthless, some questions for arsenic effects remain unexplained, reflecting the contribution of unknown factors to the manifestation of arsenic-toxicity. Interestingly, very recent studies on arsenic metabolites have discovered that trivalent methylated arsenicals show stronger cytotoxic and genotoxic potentials than inorganic arsenic or pentavalent metabolites, arguing that these metabolites could play a key role in arsenic-associated disorders. In this review, recent progress and literatures are summarized on the metabolism of trivalent methylated metabolites and their toxicity on body systems including cardiovascular system in an effort to provide an insight into the future research on arsenic-associated disorders.
Keywords
Arsenic; Trivalent arsenic metabolite$MMA^{III}$$DMA^{III}$; Toxicity;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Abernathy, C.O., Thomas, D.J. and Calderon, R.L. (2003). Health effects and risk assessment of arsenic. J. Nutr., 133, 1536S-1538S
2 Aposhian, H.V., Zheng, B., Aposhian, M.M., Le, X.C., Cebrian, M.E., Cullen, W., Zakharyan, R.A., Ma, M., Dart, R.C., Cheng, Z., Andrewes, P., Yip, L., O'Malley, G.F., Maiorino, R.M., Van Voorhies, W., Healy, S.M. and Titcomb, A. (2000b). DMPS-arsenic challenge test. II. Modulation of arsenic species, including monomethylarsonous acid (MMA(III)), excreted in human urine. Toxicol. Appl. Pharmacol., 165, 74-83   DOI   ScienceOn
3 Buchet, J.P., Pauwels, J. and Lauwerys, R. (1994). Assessment of exposure to inorganic arsenic following ingestion of marine organisms by volunteers. Environ. Res., 66, 44-51   DOI   ScienceOn
4 Edmonds, J.S., Shibata, Y., Francesconi, K.A., Rippingale, R.J. and Moritaet, M. (1997). Arsenic transformations in short marine food chains studied by HPLC-ICP MS. Appl. Organomet. Chem., 11, 281-287   DOI   ScienceOn
5 Eguchi, N., Kuroda, K. and Endo, G. (1997). Metabolites of arsenic induced tetraploids and mitotic arrest in cultured cells. Arch. Environ. Contam. Toxicol., 32, 141-145   DOI
6 Gregus, Z. and Nemeti, B. (2002). Purine nucleoside phosphorylase as a cytosolic arsenate reductase. Toxicol. Sci., 70, 13-19   DOI   ScienceOn
7 Hopenhayn-Rich, C., Biggs, M.L., Fuchs, A., Bergoglio, R., Tello, E.E., Nicolli, H. and Smith, A.H. (1996). Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology, 7, 117-124   DOI
8 Kligerman, A.D., Doerr, C.L., Tennant, A.H., Harrington-Brock, K., Allen, J.W., Winkfield, E., Poorman-Allen, P., Kundu, B., Funasaka, K., Roop, B.C., Mass, M.J. and DeMarini, D.M. (2003). Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: induction of chromosomal mutations but not gene mutations. Environ. Mol. Mutagen., 42, 192-205   DOI   ScienceOn
9 Kruger, K., Repges, H., Hippler, J., Hartmann, L.M., Hirner, A.V., Straub, H., Binding, N. and Musshoff, U. (2007). Effects of dimethylarsinic and dimethylarsinous acid on evoked synaptic potentials in hippocampal slices of young and adult rats. Toxicol. Appl. Pharmacol., 225, 40-46   DOI   ScienceOn
10 Le, X.C., Ma, M., Cullen, W.R., Aposhian, H.V., Lu, X. and Zheng, B. (2000b). Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ. Health Perspect, 108, 1015-1018   DOI
11 Lewis, D.R., Southwick, J.W., Ouellet-Hellstrom, R., Rench, J. and Calderon, R.L. (1999). Drinking water arsenic in Utah: A cohort mortality study. Environ. Health Perspect, 107, 359-365   DOI
12 Li, B., Sun, Y., Sun, X., Wang, Y., Li, X., Kumagai, Y. and Sun, G. (2007). Monomethylarsonous acid induced cytotoxicity and endothelial nitric oxide synthase phosphorylation in endothelial cells. Bull. Environ. Contam. Toxicol., 78, 455-458   DOI
13 Mead, M.N. (2005). Arsenic: in search of an antidote to a global poison. Environ. Health Perspect, 113, A378-386   DOI   ScienceOn
14 Simeonova, P.P., Hulderman, T., Harki, D. and Luster, M.I. (2003). Arsenic exposure accelerates atherogenesis in apolipoprotein E(-/-) mice. Environ. Health Perspect., 111, 1744-1748   DOI
15 Valenzuela, O.L., Borja-Aburto, V.H., Garcia-Vargas, G.G., Cruz-Gonzalez, M.B., Garcia-Montalvo, E.A., Calderon- Aranda, E.S. and Del Razo, L.M. (2005). Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Environ. Health Perspect., 113, 250-254   DOI   ScienceOn
16 Simeonova, P.P. and Luster, M.I. (2004). Arsenic and atherosclerosis. Toxicol. Appl. Pharmacol., 198, 444-449   DOI   ScienceOn
17 Styblo, M., Drobna, Z., Jaspers, I., Lin, S. and Thomas, D.J. (2002). The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ. Health Perspect., 110 Suppl 5, 767-771   DOI
18 Suzuki, K.T., Tomita, T., Ogra, Y. and Ohmichi, M. (2001). Glutathione-conjugated arsenics in the potential hepato enteric circulation in rats. Chem. Res. Toxicol., 14, 1604-1611   DOI   ScienceOn
19 Xia, Y. and Liu, J. (2004). An overview on chronic arsenism via drinking water in PR China. Toxicology, 198, 25-29   DOI   ScienceOn
20 Yu, H.S., Lee, C.H. and Chen, G.S. (2002). Peripheral vascular diseases resulting from chronic arsenical poisoning. J. Dermatol., 29, 123-130   DOI
21 Hasegawa, H., Sohrin, Y., Matsui, M., Hojo, M. and Kawashima, M. (1994). Speciation of arsenic in natural waters by solvent extraction and hydride generation atomic absorption spectrometry. Anal. Chem., 66, 3247-3252   DOI   ScienceOn
22 Lee, M.Y., Lee, Y.H., Lim, K.M., Chung, S.M., Bae, O.N., Kim, H., Lee, C.R., Park, J.D. and Chung, J.H. (2005). Inorganic arsenite potentiates vasoconstriction through calcium sensitization in vascular smooth muscle. Environ. Health Perspect., 113, 1330-1335   DOI   ScienceOn
23 Petrick, J.S., Jagadish, B., Mash, E.A. and Aposhian, H.V. (2001). Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol., 14, 651-656   DOI   ScienceOn
24 Vahter, M. (2002). Mechanisms of arsenic biotransformation. Toxicology, 181-182, 211-217   DOI   ScienceOn
25 Caceres, D.D., Pino, P., Montesinos, N., Atalah, E., Amigo, H. and Loomis, D. (2005). Exposure to inorganic arsenic in drinking water and total urinary arsenic concentration in a Chilean population. Environ. Res., 98, 151-159   DOI   ScienceOn
26 Hughes, M.F., Devesa, V., Adair, B.M., Conklin, S.D., Creed, J.T., Styblo, M., Kenyon, E.M. and Thomas, D.J. (2008). Tissue dosimetry, metabolism and excretion of pentavalent and trivalent dimethylated arsenic in mice after oral administration. Toxicol. Appl. Pharmacol., 227, 26-35   DOI   ScienceOn
27 Soucy, N.V., Klei, L.R., Mayka, D.D. and Barchowsky, A. (2004). Signaling pathways for arsenic-stimulated vascular endothelial growth factor-a expression in primary vascular smooth muscle cells. Chem. Res. Toxicol., 17, 555-563   DOI   ScienceOn
28 Bunderson, M., Brooks, D.M., Walker, D.L., Rosenfeld, M.E., Coffin, J.D. and Beall, H.D. (2004). Arsenic exposure exacerbates atherosclerotic plaque formation and increases nitrotyrosine and leukotriene biosynthesis. Toxicol. Appl. Pharmacol., 201, 32-39   DOI   ScienceOn
29 Gebel, T.W. (1999). Arsenic and drinking water contamination. Science, 283, 1458-1459
30 Chouchane, S. and Snow, E.T. (2001). In vitro effect of arsenical compounds on glutathione-related enzymes. Chem. Res. Toxicol., 14, 517-522   DOI   ScienceOn
31 Olguin, A., Jauge, P., Cebrian, M. and Albores, A. (1983). Arsenic levels in blood, urine, hair and nails from a chronically exposed human population. Proc. West Pharmacol. Soc., 26, 175-177
32 Radabaugh, T.R. and Aposhian, H.V. (2000). Enzymatic reduction of arsenic compounds in mammalian systems: reduction of arsenate to arsenite by human liver arsenate reductase. Chem. Res. Toxicol., 13, 26-30   DOI   ScienceOn
33 Wildfang, E., Radabaugh, T.R. and Aposhian, H.V. (2001). Enzymatic methylation of arsenic compounds. IX. Liver arsenite methyltransferase and arsenate reductase activities in primates. Toxicology, 168, 213-221   DOI   ScienceOn
34 Yoshida, T., Yamauchi, H. and Fan Sun, G. (2004). Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review. Toxicol. Appl. Pharmacol., 198, 243-252   DOI   ScienceOn
35 Bhattacharyya, R., Chatterjee, D., Nath, B., Jana, J., Jacks, G. and Vahter, M. (2003). High arsenic groundwater: mobilization, metabolism and mitigation--an overview in the Bengal Delta Plain. Mol. Cell. Biochem., 253, 347-355   DOI   ScienceOn
36 Hirano, S., Kobayashi, Y., Cui, X., Kanno, S., Hayakawa, T. and Shraim, A. (2004). The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds. Toxicol. Appl. Pharmacol., 198, 458-467   DOI   ScienceOn
37 Lee, M.Y., Bae, O.N., Chung, S.M., Kang, K.T., Lee, J.Y. and Chung, J.H. (2002). Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: a contributing factor to cardiovascular disease. Toxicol. Appl. Pharmacol., 179, 83-88   DOI   ScienceOn
38 Pi, J., Kumagai, Y., Sun, G., Yamauchi, H., Yoshida, T., Iso, H., Endo, A., Yu, L., Yuki, K., Miyauchi, T. and Shimojo, N. (2000). Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia. Free Radic. Biol. Med., 28, 1137-1142   DOI   ScienceOn
39 Sampayo-Reyes, A., Zakharyan, R.A., Healy, S.M. and Aposhian, H.V. (2000). Monomethylarsonic acid reductase and monomethylarsonous acid in hamster tissue. Chem. Res. Toxicol., 13, 1181-1186   DOI   ScienceOn
40 Aposhian, H.V. (1997). Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu. Rev. Pharmacol. Toxicol., 37, 397-419   DOI   ScienceOn
41 Cullen, W.R., McBride, B.C. and Reglinski, J. (1984). The reaction of methylarsenicals with thiols: Some biological implications. J. Inorg. Biochem., 21, 179-194   DOI   ScienceOn
42 Smedley P.L. and Kinniburgh D.G. (2002). A review of the source, behaviour and distribution of arsenic in natural waters. Appl. Geochem., 17, 517-568   DOI   ScienceOn
43 Berg, M., Tran, H.C., Nguyen, T.C., Pham, H.V., Schertenleib, R. and Giger, W. (2001). Arsenic contamination of groundwater and drinking water in Vietnam: a human health threat. Environ. Sci. Technol., 35, 2621-2626   DOI   ScienceOn
44 Tsou, T.C., Tsai, F.Y., Wu, M.C. and Chang, L.W. (2003). The protective role of NF-kappaB and AP-1 in arsenite-induced apoptosis in aortic endothelial cells. Toxicol. Appl. Pharmacol., 191, 177-187   DOI   ScienceOn
45 Concha, G., Vogler, G., Lezcano, D., Nermell, B. and Vahter, M. (1998). Exposure to inorganic arsenic metabolites during early human development. Toxicol. Sci., 44, 185-190   DOI
46 Del Razo, L.M., Styblo, M., Cullen, W.R. and Thomas, D.J. (2001). Determination of trivalent methylated arsenicals in biological matrices. Toxicol. Appl. Pharmacol., 174, 282-293   DOI   ScienceOn
47 Kumagai, Y. and Pi, J. (2004). Molecular basis for arsenicinduced alteration in nitric oxide production and oxidative stress: implication of endothelial dysfunction. Toxicol. Appl. Pharmacol., 198, 450-457   DOI   ScienceOn
48 Aposhian, H.V., Zakharyan, R.A., Avram, M.D., Sampayo- Reyes, A. and Wollenberg, M.L. (2004). A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species. Toxicol. Appl. Pharmacol., 198, 327-335   DOI   ScienceOn
49 Lee, T.C., Tanaka, N., Lamb, P.W., Gilmer, T.M. and Barrett, J.C. (1988). Induction of gene amplification by arsenic. Science, 241, 79-81   DOI
50 Mandal, B.K., Ogra, Y., Anzai, K. and Suzuki, K.T. (2004). Speciation of arsenic in biological samples. Toxicol. Appl. Pharmacol., 198, 307-318   DOI   ScienceOn
51 Tseng, C.H., Chong, C.K., Tseng, C.P., Hsueh, Y.M., Chiou, H.Y., Tseng, C.C. and Chen, C.J. (2003). Long-term arsenic exposure and ischemic heart disease in arseniasis- hyperendemic villages in Taiwan. Toxicol. Lett., 137, 15-21   DOI   ScienceOn
52 Zakharyan, R.A. and Aposhian, H.V. (1999). Arsenite methylation by methylvitamin B12 and glutathione does not require an enzyme. Toxicol. Appl. Pharmacol., 154, 287-291   DOI   ScienceOn
53 Shiobara, Y., Ogra, Y. and Suzuki, K.T. (2001). Animal species difference in the uptake of dimethylarsinous acid (DMA(III)) by red blood cells. Chem. Res. Toxicol., 14, 1446-1452   DOI   ScienceOn
54 Oremland, R.S. and Stolz, J.F. (2003). The ecology of arsenic. Science, 300, 939-944   DOI   ScienceOn
55 Buchet, J.P., Lauwerys, R. and Roels, H. (1981). Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int. Arch. Occup. Environ. Health, 48, 71-79   DOI
56 Jan, K.Y., Wang, T.C., Ramanathan, B. and Gurr, J.R. (2006). Dithiol compounds at low concentrations increase arsenite toxicity. Toxicol. Sci., 90, 432-439   DOI
57 Nemeti, B. and Gregus, Z. (2002). Mitochondria work as reactors in reducing arsenate to arsenite. Toxicol. Appl. Pharmacol., 182, 208-218   DOI   ScienceOn
58 Petrick, J.S., Ayala-Fierro, F., Cullen, W.R., Carter, D.E. and Aposhian, H.V. (2000). Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol., 163, 203-207   DOI   ScienceOn
59 Le, X.C., Lu, X., Ma, M., Cullen, W.R., Aposhian, H.V. and Zheng, B. (2000a). Speciation of key arsenic metabolic intermediates in human urine. Anal. Chem., 72, 5172-5177   DOI   ScienceOn
60 Bae, O.N., Lim, E.K., Lim, K.M., Noh, J.Y., Chung, S.M., Lee, M.Y., Yun, Y.P., Kwon, S.C., Lee, J.H., Nah, S.Y., and Chung, J.H. (2008). Vascular smooth muscle dysfunction induced by monomethylarsonous acid ($MMA^{III}$): A contributing factor to arsenic-associated cardiovascular diseases. Environ. Res., doi:10.1016/j.envres.2008.06.012
61 Mass, M.J., Tennant, A., Roop, B.C., Cullen, W.R., Styblo, M., Thomas, D.J. and Kligerman, A.D. (2001). Methylated trivalent arsenic species are genotoxic. Chem. Res. Toxicol., 14, 355-361   DOI   ScienceOn
62 Vahter, M. and Marafante, E. (1983). Intracellular interaction and metabolic fate of arsenite and arsenate in mice and rabbits. Chem. Biol. Interact., 47, 29-44   DOI   ScienceOn
63 Styblo, M., Serves, S.V., Cullen, W.R. and Thomas, D.J. (1997). Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol., 10, 27-33   DOI   ScienceOn
64 Bae, O.N., Lim, K.M., Noh, J.Y., Chung, S.M., Kim, H., Lee, C.R., Park, J.D. and Chung, J.H. (2007). Arsenite-enhanced procoagulant activity through phosphatidylserine exposure in platelets. Chem. Res. Toxicol., 20, 1760-1768   DOI   ScienceOn
65 Liu, Z., Shen, J., Carbrey, J.M., Mukhopadhyay, R., Agre, P. and Rosen, B.P. (2002). Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9. Proc. Natl. Acad. Sci. USA, 99, 6053-6058
66 Hirano, S., Cui, X., Li, S., Kanno, S., Kobayashi, Y., Hayakawa, T. and Shraim, A. (2003). Difference in uptake and toxicity of trivalent and pentavalent inorganic arsenic in rat heart microvessel endothelial cells. Arch. Toxicol., 77, 305-312   DOI
67 Nesnow, S., Roop, B.C., Lambert, G., Kadiiska, M., Mason, R.P., Cullen, W.R. and Mass, M.J. (2002). DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem. Res. Toxicol., 15, 1627-1634   DOI   ScienceOn
68 Hayakawa, T., Kobayashi, X., Cui, X. and Hirano, S. (2005). A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch. Toxicol., 79, 183-191   DOI
69 Lin, S., Del Razo, L.M., Styblo, M., Wang, C., Cullen, W.R. and Thomas, D.J. (2001). Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes. Chem. Res. Toxicol., 14, 305-311   DOI   ScienceOn
70 Sakurai, T., Qu, W., Sakurai, M.H. and Waalkes, M.P. (2002). A major human arsenic metabolite, dimethylarsinic acid, requires reduced glutathione to induce apoptosis. Chem. Res. Toxicol., 15, 629-637   DOI   ScienceOn
71 Lamm, S.H., Engel, A., Kruse, M.B., Feinleib, M., Byrd, D.M., Lai, S. and Wilson, R. (2004). Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 U.S. counties and 30 years of observation. J. Occup. Environ. Med., 46, 298-306   DOI   ScienceOn
72 Lee, M.Y., Jung, B.I., Chung, S.M., Bae, O.N., Lee, J.Y., Park, J.D., Yang, J.S., Lee, H. and Chung, J.H. (2003). Arsenic-induced dysfunction in relaxation of blood vessels. Environ. Health Perspect., 111, 513-517
73 Styblo, M., Del Razo, L.M., Vega, L., Germolec, D.R., LeCluyse, E.L., Hamilton, G.A., Reed, W., Wang, C., Cullen, W.R. and Thomas, D.J. (2000). Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol., 74, 289-299   DOI
74 Heydorn, K. (1970). Environmental variation of arsenic levels in human blood determines by neutron activation analysis. Clin. Chim. Acta, 28, 349-357   DOI   ScienceOn
75 Kwok, R.K., Mendola, P., Liu, Z.Y., Savitz, D.A., Heiss, G., Ling, H.L., Xia, Y., Lobdell, D., Zeng, D., Thorp, J.M. Jr., Creason, J.P. and Mumford, J.L. (2007). Drinking water arsenic exposure and blood pressure in healthy women of reproductive age in Inner Mongolia, China. Toxicol. Appl. Pharmacol., 222, 337-343   DOI   ScienceOn
76 Aposhian, H.V., Gurzau, E.S., Le, X.C., Gurzau, A., Healy, S.M., Lu, X., Ma, M., Yip, L., Zakharyan, R.A., Maiorino, R.M., Dart, R.C., Tircus, M.G., Gonzalez-Ramirez, D., Morgan, D.L., Avram, D. and Aposhian, M.M. (2000a). Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem. Res. Toxicol., 13, 693-697   DOI   ScienceOn
77 Bates, M.N., Smith, A.H. and Hopenhayn-Rich, C. (1992). Arsenic ingestion and internal cancers: a review. Am. J. Epidemiol., 135, 462-476   DOI
78 Cebrian, M.E., Albores, A., Aguilar, M. and Blakely, E. (1983). Chronic arsenic poisoning in the north of Mexico. Hum. Toxicol., 2, 121-133   DOI